Trastuzumab: a guide to its use in early breast cancer

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.24, Iss.12, 2008-12, pp. : 4-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Trastuzumab: A Pharmacoeconomic Review of its Use in Early Breast Cancer

By McKeage Kate Lyseng-Williamson Katherine A.

PharmacoEconomics, Vol. 26, Iss. 8, 2008-01 ,pp. : 699-719

Adis International

Access to resources Recommend Favorite

Trastuzumab: A Review of its Use in the Management of HER2-Positive Metastatic and Early-Stage Breast Cancer

By Plosker Greg L. Keam Susan J.

Drugs, Vol. 66, Iss. 4, 2006-01 ,pp. : 449-475

Adis International

Access to resources Recommend Favorite

In defence of trastuzumab for early breast cancer

Inpharma, Vol. 1, Iss. 1521, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Trastuzumab: A Review of its Use as Adjuvant Treatment in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer

By Garnock-Jones Karly P. Keating Gillian M. Scott Lesley J.

Drugs, Vol. 70, Iss. 2, 2010-01 ,pp. : 215-239

Adis International

Access to resources Recommend Favorite

Trastuzumab without an anthracycline: better for early breast cancer

Inpharma, Vol. 1, Iss. 1574, 2007-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite